Steven K. Libutti, MD

Steven K. Libutti, MD, FACS is the William N. Hait Director of Rutgers Cancer Institute, Vice Chancellor for Cancer Programs, Rutgers and the Senior Vice President of Oncology Services, RWJBarnabas Health. He is a Distinguished Professor of Surgery, Rutgers Robert Wood Johnson Medical School and an Affiliated Distinguished Professor in Genetics, Rutgers School of Arts and Sciences.

Dr. Libutti is an internationally known expert in the management of neuroendocrine tumors, Past President of American Association of Endocrine Surgeons and a member of American Surgical Association and Association of American Physicians. His clinical practice focuses on gastrointestinal malignancies including liver and pancreatic cancers. Funded by the National Cancer Institute for 25 years, Dr. Libutti’s work focuses on developing novel cancer therapies through an understanding of the tumor microenvironment as well as on a better understanding of the tumor suppressor genes MEN1 and FILIP1L. He has published over 325 peer reviewed journal articles, is Editor-in-Chief Emeritus of the Springer-Nature Journal Cancer Gene Therapy and holds eleven U.S. patents.

After graduating magna cum laude from Harvard College, Dr. Libutti received his medical degree from the College of Physicians and Surgeons, Columbia University. He remained at Presbyterian Hospital in New York and completed his residency in surgery, followed by a fellowship at the NCI in surgical oncology. He continued at the NCI where he became a tenured Senior Investigator and Chief, Tumor Angiogenesis Section in the Surgery Branch. Following his time at the NCI, he served as the Director of the Montefiore Einstein Center for Cancer Care and Associate Director, Albert Einstein Cancer Center prior to joining Rutgers and RWJBarnabas Health.

Clinical Interests:

Neuroendocrine tumors, thyroid cancer, parathyroid tumors, pancreatic cancer, liver cancer, GI cancers, minimally invasive surgery, and clinical trials.